55 members of Congress have disclosed 424 trades in Abbott Laboratories (ABT) since 2013: 206 purchases worth about $4.84M and 217 sales worth about $6.45M. The most active was Thomas H. Kean, Jr., with 5 trades. The latest trade was made on Oct 2, 2026.
ABT’s price and SPY’s, both as the change since the start of the range. A green triangle marks a day members bought ABT, a red one a day they sold; hover for who and how much.
| # | Member | Trades | Buys | Sells | Bought (est.) | Sold (est.) | Net | Buys vs SPY | First Traded | Last Traded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Thomas H. Kean, Jr.R-NJ | 5 | 4 | 1 | $32.00K | $8.00K | +$24.00K | -22.8% | Jul 23, 2024 | Sep 17, 2026 |
| 2 | Pete SessionsR-TX | 3 | 2 | 1 | $40.50K | $75.00K | -$34.50K | -120.7% | Jul 27, 2015 | Oct 2, 2026 |
| 3 | Gilbert Ray Cisneros, Jr.D-CA | 7 | 4 | 3 | $32.00K | $24.00K | +$8.00K | -43.3% | Mar 18, 2020 | Sep 18, 2026 |
| 4 | Ro KhannaD-CA | 145 | 78 | 67 | $1.24M | $1.22M | +$16.01K | -66.9% | Jan 24, 2017 | Sep 4, 2026 |
| 5 | Rick W. AllenR-GA | 4 | 2 | 2 | $65.00K | $65.00K | $0.00 | -119.4% | Sep 13, 2019 | Jul 14, 2026 |
| 6 | Richard McCormickR-GA | 6 | 5 | 1 | $40.00K | $8.00K | +$32.00K | -13.4% | Mar 15, 2023 | Jul 30, 2026 |
| 7 | Mike KellyR-PA | 3 | 1 | 2 | $8.00K | $16.00K | -$8.00K | -78.5% | Jun 23, 2016 | Jul 17, 2026 |
| 8 | Rick LarsenD-WA | 3 | 1 | 2 | $8.00K | $16.00K | -$8.00K | -29.5% | Jan 6, 2023 | Jul 8, 2026 |
| 9 | Julie JohnsonD-TX | 4 | 0 | 4 | $0.00 | $32.00K | -$32.00K | – | Aug 14, 2025 | May 12, 2026 |
| 10 | Josh GottheimerD-NJ | 11 | 7 | 4 | $56.00K | $32.00K | +$24.00K | -63.0% | Feb 27, 2019 | May 27, 2026 |
| 11 | Laura FriedmanD-CA | 1 | 0 | 0 | $0.00 | $0.00 | $0.00 | – | Mar 24, 2026 | Mar 24, 2026 |
| 12 | Michael T. McCaulR-TX | 102 | 43 | 59 | $2.30M | $3.71M | -$1.41M | -89.3% | Apr 22, 2014 | Mar 4, 2026 |
| 13 | Julia LetlowR-LA | 2 | 1 | 1 | $8.00K | $8.00K | $0.00 | -35.9% | Oct 23, 2024 | Dec 8, 2025 |
| 14 | Byron DonaldsR-FL | 4 | 2 | 2 | $16.00K | $16.00K | $0.00 | -46.0% | Mar 20, 2025 | Dec 4, 2025 |
| 15 | Lisa C. McClainR-MI | 2 | 1 | 1 | $8.00K | $8.00K | $0.00 | -44.1% | Jun 24, 2025 | Jul 10, 2025 |
| Owner | Type | Filing | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Thomas H. Kean, Jr.R-NJ | ABTAbbott Laboratories Common Stock | Self | Sell (Partial) | $1K–$15K | Sep 17, 2026 | Oct 30, 2026 | 43d | +7.9% | +9.2% | |
| Pete SessionsR-TX | ABTAbbott Laboratories Common Stock | Spouse | Sell | $50K–$100K | Oct 2, 2026 | Oct 27, 2026 | 25d | +13.1% | +15.4% | |
| Gilbert Ray Cisneros, Jr.D-CA | ABTAbbott Laboratories Common Stock | Self | Buy | $1K–$15K | Sep 18, 2026 | Oct 12, 2026 | 24d | +7.5% | +8.8% | |
| Ro KhannaD-CA | ABTABBOTT LABORATORIES CMN | Spouse | Buy | $1K–$15K | Sep 4, 2026 | Oct 7, 2026 | 33d | +1.8% | +4.1% | |
| Rick W. AllenR-GA | ABTAbbott Laboratories Common Stock | Spouse | Sell | $15K–$50K | Jul 14, 2026 | Aug 18, 2026 | 35d | +24.0% | +23.9% | |
| Richard McCormickR-GA | ABTAbbott Laboratories Common Stock | Self | Sell | $1K–$15K | Jul 30, 2026 | Aug 14, 2026 | 15d | +4.4% | +3.0% | |
| Mike KellyR-PA | ABTAbbott Laboratories Common Stock | Spouse | Sell | $1K–$15K | Jul 17, 2026 | Aug 12, 2026 | 26d | +9.5% | +8.3% | |
| Rick LarsenD-WA | ABTAbbott Laboratories Common Stock | Self | Sell | $1K–$15K | Jul 8, 2026 | Jul 12, 2026 | 4d | +15.9% | +14.9% | |
| Richard McCormickR-GA | ABTAbbott Laboratories Common Stock | Self | Buy | $1K–$15K | Jun 12, 2026 | Jul 9, 2026 | 27d | +25.1% | +23.6% | |
| Richard McCormickR-GA | ABTAbbott Laboratories Common Stock | Self | Buy | $1K–$15K | Jun 12, 2026 | Jul 9, 2026 | 27d | +25.1% | +23.6% | |
| Ro KhannaD-CA | ABTABBOTT LABORATORIES CMN | Spouse | Buy | $1K–$15K | Jun 30, 2026 | Jul 6, 2026 | 6d | +21.5% | +20.8% | |
| Ro KhannaD-CA | ABTABBOTT LABORATORIES | Spouse | Sell | $1K–$15K | Jun 23, 2026 | Jul 6, 2026 | 13d | +21.8% | +19.3% | |
| Ro KhannaD-CA | ABTABBOTT LABORATORIES | Dependent Child | Sell | $1K–$15K | Jun 23, 2026 | Jul 6, 2026 | 13d | +21.8% | +19.3% | |
| Ro KhannaD-CA | ABTABBOTT LABORATORIES | Dependent Child | Sell | $1K–$15K | Jun 23, 2026 | Jul 6, 2026 | 13d | +21.8% | +19.3% | |
| Ro KhannaD-CA | ABTABBOTT LABORATORIES CMN | Dependent Child | Buy | $1K–$15K | May 2, 2026 | Jul 6, 2026 | 65d late | +23.3% | +18.9% |
Tip. Hover a row for the filing’s full asset text and comments; the PDF link opens the report itself.
55 members of Congress have disclosed 424 trades in Abbott Laboratories (ABT) since 2013: 206 purchases worth about $4.84M and 217 sales worth about $6.45M. The most active was Thomas H. Kean, Jr., with 5 trades. The latest trade was made on Oct 2, 2026. Most active: Thomas H. Kean, Jr. (5), Pete Sessions (3), Gilbert Ray Cisneros, Jr. (7), Ro Khanna (145), Rick W. Allen (4).
Since 2013 they have disclosed 206 purchases and 217 sales; by the midpoints of the disclosed ranges, about $4.84M bought and $6.45M sold, a net sale of $1.61M.
Members of Congress report each trade over $1,000 within 45 days under the STOCK Act, with the amount as a range. The chart marks the days members traded ABT on its price, against the S&P 500 over the same days.
Members of Congress disclose trades as dollar ranges, up to 45 days after the trade and sometimes later. Volumes use the midpoints of those ranges and are estimates; portfolio figures are a model built from the disclosed trades, not the members’ actual accounts. Not investment advice.